Natural Product Drug Discovery in the Next Millennium

References

• Adams MW, Kelly RM (1998): Finding and using hyperther-mophilic enzymes. Trends in Biotech 16: 329-332. Anonymous (1998): A pictorial history of herbs in medicine andpharmacy. Herbalgram 42: 33–37.
   Google Scholar
• Anonymous (1999): New treatment for CML could be model for molecular target-based therapeutics. The Cancer Letter 25: 1–4.
   Google Scholar
• Arvigo R, Balick M (1993): Rainforest Remedies. Twin Lakes, Wisconsin, Lotus Press.
   Google Scholar
• Ayensu ES (1981): Medicinal Plants of the West Indies. Algonac, Michigan, Reference Publications.
   Google Scholar
• Baker JT, Borris RP, Carte B, Cordell GA, Soejarto DD, Cragg GM, Gupta MP, Iwu MM, Madulid DR, Tyler VE (1995): Natural product drug discovery and development: new per-spectives on international collaboration. J Nat Prod 58: 1325–1357.
   PubMed Web of Science ®Google Scholar
• Balandrin MF, Kinghorn AD, Farnsworth NR (1993): Plant-derived natural products in drug discovery and develop-ment. An overview. In: Kinghorn AD, Balandrin MF, eds., Human Medicinal Agents from Plants, Washington, DC, Amer Chem Soc, pp. 2–12.
   Google Scholar
• Borman S (1999): Four types of natural products that stabilize cell microtubules share structural features. C&EN April 26 Issue: 35–36.
   Google Scholar
• Buss AD, Waigh RD (1995): Natural products as leads for new pharmaceuticals. In: Wolff ME, eds., Burgers Medicinal Chemistry and Drug Discovery Fifth Edition Vol. 1, New York, John Wiley & Sons, pp. 983–1033.
   Google Scholar
• Carte BK (1996): Biomedical potential of marine natural prod-ucts. Bio-Science 46: 271–286.
   Web of Science ®Google Scholar
• Chang HIM, But P-H (1986): Pharmacology and Applications of Chinese Materia Medica Vols 1 & 2, Singapore, World Scientific Publishing.
   Google Scholar
• Colwell RR (1997): Microbial diversity: the importance of exploration and conservation. J Ind Microbiol Biotech 18: 302–307.
   PubMedGoogle Scholar
• Cortes JE, Pazdur R (1995): Docetaxel. J Clin Oncol 13: 2643–2655.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Boyd MR, Cardellina II JH, Newman DJ, Snader KM, McCloud TG (1994): Ethnobotany and the search for new drugs. In: Chadwick DJ, Marsh J, eds., Ciba Founda-tion Symposium Vol. 185, Chichester, U.K., Wiley & Sons, pp. 178–196.
   Google Scholar
• Cragg GM, Newman DJ, Snader KM (1997a): Natural products in drug discovery and development. J Nat Prod 60: 52–60.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Newman DJ, Weiss RB (1997b): Coral reefs, forests, and thermal vents: the worldwide exploration of nature for novel antitumor agents. Sem Oncol 24: 156–163.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Schepartz SA, Suffriess M, Greyer MR (1993): The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. J Nat Prod 56: 1657–1668.
   Google Scholar
• Daly JAW (1998): Thirty years of discovering arthropod alkaloids in amphibian skin. J Nat Prod 61: 162–172.
   PubMed Web of Science ®Google Scholar
• Fallarino M (1994): Tibetan medical paintings. Herbalgram 31: 38 /4.
   Google Scholar
• Farnsworth NR, Akerele 0, Bingel AS, Soejarto DD, Guo Z (1985): Medicinal plants in therapy. Bull WHO 63: 965–981.
   PubMed Web of Science ®Google Scholar
• Flavin MT, Rizzo JD, Khilevich A, Kucherenko A, Sheinkman AK, Vilaychack V, Lin L, Chen W, Greenwood EM, Peng-suparp T, Pezzuto J, Hughes SH, Flavin TM, Cibulski M, Boulanger WA, Shone RL, Xu Z-Q (1996): Synthesis, chro-matographic resolution, and anti-human immunodeficiency virus activity of (+/—)-calanolide A and its enantiomers. J Med Chem 39: 1303–1313.
   PubMed Web of Science ®Google Scholar
• Foye WO (1995): Cancer Chemotherapeutic Agents, ACS Professional Reference Book, Washington, D. C., Amer. Chem. Soc.
   Google Scholar
• Gokhale RS, Tsuji SY, Cane DE, Khosla C (1999): Dissecting and exploiting intermodular communication in polyketide synthases. Science 284: 482–485.
   PubMed Web of Science ®Google Scholar
• Gupta MP, Ed. (1995): 270 Plantas Medicinales Iberoameri-canas. Bogota, Colombia, Talleres de Edioral Presencia Ltda.
   Google Scholar
• Haar E, Kowalski RJ, Lin CM, Longley RE, Gunasekera SP, Rosenkranz HS, Day BW (1996): Discodermolide, a cyto-toxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry 35: 243–250.
   PubMed Web of Science ®Google Scholar
• Handelsman J, Rondon MR, Brady SF, Clardy J, Goodman RM (1998): Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem & Biol 5: R245—R249.
   PubMed Web of Science ®Google Scholar
• Hartwell JL (1982): Plants Used Against Cancer, Lawrence, Massachusetts, Quarterman.
   Google Scholar
• Horan AC (1994): Actinomycetes. In: Gullo VP, ed., The Dis-covery of Natural Products with Therapeutic Potential, Boston, Butterworth-Heinemann, pp. 3–30.
   Google Scholar
• Hutchinson CR (1999): Microbial polyketide synthases: moreand more prolific. Proc Nall Acad Sci USA 96: 3336–3338. Iwu MM (1993): Handbook of African Medicinal Plants, BocaRaton, Florida, CRC Press.Jain SK (1991): Medicinal Plants of India, Algonac, Michigan, Reference Publications.
   Google Scholar
• Kapoor LD (1990): Handbook of Ayurvedic Medicinal Plants, Boca Raton, Florida, CRC Press.
   Google Scholar
• Kashman Y, Gustafson KR, Fuller RW, Cardellina II JH, McMahon JB, Currens MJ, Buckheit RW, Hughes SH, Cragg GM, Boyd MR (1992): The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem 35: 2735–2743.
   PubMed Web of Science ®Google Scholar
• Long BH, Carboni JM, Wasserman AJ, Cornell LA, Casazza AM, Jensen PR, Lindel T, Fenical W, Fairchild CR (1998): Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel. Cancer Res 58: 1111–1115.
   PubMed Web of Science ®Google Scholar
• Lutz RA, Kennish MJ (1993): Ecology of deep-sea hydrother-mal vent communities: A review. Reviews of Geophysics 31: 211–242.
   Web of Science ®Google Scholar
• Lutz RA, Shank TM, Fornari DJ (1994): Rapid growth at deep sea vents. Nature 371: 663–664.
   Web of Science ®Google Scholar
• Martinez EJ, Owa T, Schreiber SL, Corey EJ (1999): Phthalas-cidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743. Proc Nall Acad Sci USA 96: 3496–3501.
   PubMed Web of Science ®Google Scholar
• Mays TD, Mazan KD, Cragg GM, Boyd MR (1997): "Triangu-lar Privity" — a working paradigm for the equitable sharing of benefits from biodiversity research and development. In: Hoagland KE, Rossman AY, eds., Global Genetic Resources: Access, Ownership, and Intellectual Property Rights, Washington, D. C., Association of Systematics Collections, pp. 279–298.
   Google Scholar
• McConnell 0, Longley RE, Koehn FE (1994): The discovery of marine natural products with therapeutic potential. In: Gullo VP, ed., The Discovery of Natural Products with Therapeutic Potential, Boston, Butterworth-Heinemann, pp. 109–174.
   Google Scholar
• Nicolaou KC, Roschangar F, Vourloumis D (1998a): Chemical biology of the epothilones. Angew Chem Int Ed 37: 2014–2045.
   Google Scholar
• Nicolaou KC, Kim S, Pfefferkorn J, Xu J, Oshima T, Hosokawa S, Vourloumis D, Li T (1998b): Synthesis and biological activity of sarcodictyins. Angew Chem Int Ed 37: 1418–1421.
   PubMed Web of Science ®Google Scholar
• Olivera BM (1997): Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neu-ropharmacology. Mol Biol Cell 8: 1–9.
   PubMedGoogle Scholar
• Persidis A (1998): Extremophiles. Nature Biotechnology 16: 593–594.
   PubMed Web of Science ®Google Scholar
• Philip PA, Rea D, Thavasu P, Carmichel J, Stuart NSA, Rockett H, Talbot DC, Ganesan T, Pettit GR, Balkwill F, Harris AL (1993): Phase I study of bryostatin 1: assessment of inter-leukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee. J Natl Cancer Inst 85: 1812–1818.
   Google Scholar
• Potmeisel M, Pinedo H (1995): Camptothecins. New Anticancer Agents, Boca Raton, Florida, CRC Press.
   Google Scholar
• Psenner R, Sattler B (1998): Life at the freezing point. Science 280: 2073–2074.
   PubMed Web of Science ®Google Scholar
• Schreiber SL (1998): Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg & Med Chem 6: 1127–1152.
   PubMed Web of Science ®Google Scholar
• Schreiber SL, Tan DS, Foley MA, Shair MD (1998): Stereose-lective synthesis of over two million compounds having structural features both reminiscent of natural products and compatible with miniaturized cell-based assays. J Amer Chem Soc 120: 8565–8566.
   Google Scholar
• Schultes RE, Raffauf RF (1990): The Healing Forest, Portland, Oregon, Dioscorides Press.
   Google Scholar
• Service RF (1999): Race for molecular summits. Science 285: 184–187.
   PubMedGoogle Scholar
• Ten Kate K, Wells A (1998). Benefit-Sharing Case Study. The access and benefit-sharing policies of the United States National Cancer Institute: a comparative account of the dis-covery and development of the drugs Calanolide and Topotecan. Submission to the Executive Secretary of the Convention on Biological Diversity. Kew, U.K., The Royal Botanic Gardens.
   Google Scholar
• Wender PA, DeBrabander J, Harran PG, Jiminez J-M, Koehler
   Google Scholar
• MFT, Lippa B, Park C-M, Siedenbiedel C, Pettit GR (1998): The design, computer modeling solution structure, and biological evaluation of synthetic analogs of bryostatin 1. Proc Nati Acad Sci USA 95: 6624–6629.
   PubMedGoogle Scholar
• Young P (1997): Major microbial diversity initiative recom-mended. ASM News 63: 417–421.
   Google Scholar
• Zhang B, Salituro G, Szalkowski D, Zhang Z, Li Y, Royo I, Vilella D, Diez MT, Pelaez F, Ruby C, Kendall RL, Mao X, Griffin P, Calaycay J, Zierath J, Heck JV, Smith RG, Moller DE (1999): Discovery of a small molecule insulin mimetic with anti-diabetic activity in mice. Science 284: 974–976.
   PubMed Web of Science ®Google Scholar
• Hsiang Y-H, Hertzberg R, Hecht S, Liu L (1985): Camptothecin induces protein-linked breaks via mammalian DNA topoi-somerase I. J Biol Chem 260: 14873–14878.
   PubMed Web of Science ®Google Scholar
• Kingston DGI (2000): Recent advances in the chemistry of taxol. J Nat Prod 63: 726–734.
   PubMed Web of Science ®Google Scholar
• Schiff PB, Pant J, Horwitz SB (1979): Promotion of microtubule assembly in vitro by taxol. Nature 277: 665–667.
   PubMed Web of Science ®Google Scholar
• Simmonds MSJ, Grayer RJ (1999): Drug discovery and devel-opment. In: Walton NJ, Brown DE, eds., Chemistry of Plants. Imperial College Press, London. pp. 215-249.
   Google Scholar
• Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA (1966): Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc 88: 3888–3890.
   Google Scholar
• Wani MC, Taylor HL, Wall ME, Coggin P, McPhail AT (1971): Plant antitumor agents: VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325–2327.
   Google Scholar
• Zhao H, Lee C, Sai P, Choe YH, Boro M, Pendri A, Guan S, Greenwald RB (2000): 20-0-Acylcamptotecin derivatives: Evidence for lactone stabilization. J Org Chem 65: 4601–4606.
   PubMed Web of Science ®Google Scholar